Cancer stem cells in multiple myeloma.

Cancer stem cells in multiple myeloma.
复制标题

DOI:
10.1016/j.canlet.2008.08.005
复制
发表时间:
2009-05-08
期刊:
影响因子:
9.7
通讯作者:
Matsui, William
Matsui, William
中科院分区:
医学1区
文献类型:
--
作者:
Ghosh, Nilanjan;Matsui, William

文献摘要

参考文献

被引文献

相似文献

多发性骨髓瘤的研究提供了癌症干细胞假说的证据和对这些细胞独特生物学的见解。这些证据包括癌细胞可能是功能异质性的,尽管它们的遗传同质性和恶性祖细胞与正常成体干细胞共享许多生物学特征,包括耐药性和自我更新的调控过程。我们回顾了研究多发性骨髓瘤中的克隆形成细胞,强调了关于多发性骨髓瘤起源细胞的争议,并讨论了潜在的靶向策略。
Several key observations providing evidence for the cancer stem cell hypothesis and insights into the unique biology of these cells have come from the study of multiple myeloma. These include evidence that cancer cells may be functionally heterogeneous in spite of their genetic homogeneity and that malignant progenitors share many biological features with normal adult stem cells including drug resistance and regulatory processes governing self-renewal. We review studies that have examined clonogenic cells in multiple myeloma, highlight controversies regarding the cell of origin in multiple myeloma, and discuss potential targeting strategies.
DOI: 10.1080/10428190500272473
发表时间: 2006-01-01
影响因子: 2.6
作者:
Bendandi, M;Rodríguez-Calvillo, M;Orfao, A
通讯作者: Orfao, A
DOI: 10.1080/146532402761624638
发表时间: 2002-10-01
期刊: CYTOTHERAPY
影响因子: 4.5
作者:
Goodell, MA
通讯作者: Goodell, MA
DOI: 10.1073/pnas.0703478104
发表时间: 2007-06-12
影响因子: 11.1
作者:
Dalerba, Piero;Dylla, Scott J.;Clarke, Michael F.
通讯作者: Clarke, Michael F.
DOI: 10.1182/blood.v85.2.436.bloodjournal852436
发表时间: 1995-01-15
期刊: BLOOD
影响因子: 20.3
作者:
BERGSAGEL, PL;SMITH, AM;PILARSKI, LM
通讯作者: PILARSKI, LM
DOI: 10.1016/s0167-5699(00)01605-4
发表时间: 2000-05-01
期刊: IMMUNOLOGY TODAY
影响因子: --
作者:
Agematsu, K;Hokibara, S;Komiyama, A
通讯作者: Komiyama, A